A 90-day oral toxicity study on a new strain of Lactobacillus paracasei in rats

Food and Chemical Toxicology

Volumn 49, Issue 5, 2011, Pages 1148-1151

  Jia, X ^a   Wang, W ^a   Song, Y ^a   Li, N ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Lactobacillus paracasei; NOAEL; Rat; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; NITROGEN; PROBIOTIC AGENT; TRIACYLGLYCEROL; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; LACTOBACILLUS PARACASEI; LIVER NECROSIS; LYMPHOCYTE COUNT; MALE; MICROSCOPY; MORTALITY; NEUTROPHIL COUNT; NONHUMAN; RAT; THROMBOCYTE COUNT; TOXICITY TESTING; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EATING; FEMALE; HEMATOLOGIC TESTS; LACTOBACILLUS; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; PROBIOTICS; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS, CHRONIC;

ANIMALIA; LACTOBACILLUS PARACASEI; RATTUS;

EID: 79953059349     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2011.02.006     Document Type: Article

References (18)

1. Angelis M., Corsetti A., Tosti N., Rossi J., Corbo M.R., Gobbetti M. Characterization of non-starter lactic acid bacteria from Italian ewe cheeses based on phenotypic, genotypic, and cell wall protein analyses. Appl. Environ. Microbiol. 2001, 67:2011-2020.
2. Atanassova M., Choiset Y., Dalgalarrondo M., Chobert J.-M., Dousset X., Ivanova I., Haertké T. Isolation and partial biochemical characterization of a proteinaceous anti-bacteria and anti-yeast compound produced by Lactobacillus paracasei subsp. paracasei strain M3. Int. J. Food. Microbiol. 2003, 87:63-73.
3. Donohue D.C., Deighton M., Ahokas J.T., Salminen S. Toxicity of lactic acid bacteria. Lactic Acid Bacteria 1993, Marcel Dekker Inc., NY, (p. 307-317). S. Salminen, A. von Wright (Eds.).
4. Donohue D.C., Salminen S. Safety of probiotic bacteria. Asia Pac. J. Clin. Nutr. 1996, 5:25-28.
5. FDA 2007. Subchronic toxicity studies with rodents. In: Guidance for Industry and Other Stakeholders. US Food and Drug Administration (FDA), Maryland, USA, Toxicological Principles for the Safety Assessment of Food Ingredients Redbook 2000.
6. Felis G.E., Dellaglio F. Taxonomy of lactobacilli and bifidobacteria. Curr. Issues Intestinal Microbiol. 2007, 8:44-61.
7. Fuller R. History and development of probiotics. Probiotics - The Scientific Basis 1992, Champman and Hall, London, (p. 1-18). R. Fuller (Ed.).
8. Gardiner G., Ross R.P., Collins J.K., Fitzgerald G., Stanton C. Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl. Environ. Microbiol. 1998, 64:2192-2199.
9. Kailasapathy K., Rybka S. L. acidophilus and Bifidobacterium spp. - their therapeutic potential and survival in yoghurt. Austr. J. Dairy Technol. 1997, 52:28-35.
10. Monose H., Igara M., Era T., Fukuda Y., Yamada M., Ogasa K. Toxicological studies on Bifidobacterium longum BB-536. Pharmacometrics 1979, 17:881-887.
11. Ocaña V.S., Holgado A.A.P.de R., Nader-Macias M.E. Growth inhibition of Staphylococcus aureus by H2O2-producing Lactobacillus paracasei subsp. paracasei isolated from the human vagina. FEMS Immunol. Med. Microbiol. 1999, 23:87-92.
12. Park S.Y., Ji G.E., Ko Y.T., Jung H.K., Ustunol Z., Pestka J.J. Potentiation of hydrogen peroxide, nitric oxide and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 1999, 46:231-241.
13. Reid G., Jass J., Sebulsky M.T., McCormick J.K. Potential uses of probiotics in clinical practice. Clin. Microbiol. Rev. 2003, 16(4):658-672.
14. Salminen S., Deghton M., Gorbach S. Lactic acid bacteria in health and disease. Lactic Acid Bacteria 1974, 199-226. Marcel Dekker Inc., NY. S. Salminen, A. von Wright (Eds.).
15. Sanders M.E. Considerations for use of probiotic bacteria to modulate human health. J. Nutr. 2000, 130:384S-390S.
16. Saxelin M., Rautelin H., Salminen S., Makela P.H. Safety of commercial products with viable Lactobacillus strains. Infect. Dis. Clin. Pract. 1996, 5:331-335.
17. Sookkhee S., Chulasiri M., Prachyabrued W. Lactic acid bacterial form healthy oral cavity of Thai volunteers: inhibition of oral pathogens. J. Appl. Microbiol. 2001, 90:172-179.
18. Yoon K.Y., Woodams E.E., Hang Y.D. Probiotication of tomato juice by lactic acid bacteria. J. Microbiol. 2004, 42:315-318.